{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:23:00Z","timestamp":1762978980532,"version":"3.45.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1930"],"award-info":[{"award-number":["2024NSFSC1930"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctor Research Fund of West China Hospital, Sichuan University","award":["2023HXBH029","2023HXBH104"],"award-info":[{"award-number":["2023HXBH029","2023HXBH104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23412-1","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:52:24Z","timestamp":1762973544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan-cancer landscape of cellular senescence heterogeneity reveals associations with prognosis and therapy response"],"prefix":"10.1038","volume":"15","author":[{"given":"Linyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongshu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidian","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"1","key":"23412_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74 (1), 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"23412_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane, M. & Weeraratna, A. T. How the ageing microenvironment influences tumour progression. Nat. Rev. Cancer. 20 (2), 89\u2013106 (2020).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"23412_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cmet.2022.11.001","volume":"35","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L. & Kroemer, G. Meta-hallmarks of aging and cancer. Cell. Metab. 35 (1), 12\u201335 (2023).","journal-title":"Cell. Metab."},{"issue":"5","key":"23412_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/febs.16231","volume":"290","author":"T Yasuda","year":"2023","unstructured":"Yasuda, T., Baba, H. & Ishimoto, T. Cellular senescence in the tumor microenvironment and context-specific cancer treatment strategies. FEBS J. 290 (5), 1290\u20131302 (2023).","journal-title":"FEBS J."},{"key":"23412_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2022.11.007","volume":"135","author":"SN Zarneshan","year":"2023","unstructured":"Zarneshan, S. N., Fakhri, S., Bachtel, G. & Bishayee, A. Exploiting pivotal mechanisms behind the senescence-like cell cycle arrest in cancer. Adv. Protein Chem. Struct. Biol. 135, 1\u201319 (2023).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"2","key":"23412_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco, R., Krizhanovsky, V., Baker, D. & d\u2019Adda Di Fagagna, F. Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell. Biol. 22 (2), 75\u201395 (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"5","key":"23412_CR7","doi-asserted-by":"publisher","first-page":"e14182","DOI":"10.1111\/acel.14182","volume":"23","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy. Aging Cell. 23 (5), e14182 (2024).","journal-title":"Aging Cell."},{"issue":"2","key":"23412_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","volume":"7","author":"M Demaria","year":"2017","unstructured":"Demaria, M. et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 7 (2), 165\u2013176 (2017).","journal-title":"Cancer Discov."},{"issue":"12","key":"23412_CR9","doi-asserted-by":"publisher","first-page":"e00586","DOI":"10.1128\/MCB.00586-18","volume":"39","author":"L Lau","year":"2019","unstructured":"Lau, L., Porciuncula, A., Yu, A., Iwakura, Y. & David, G. Uncoupling the Senescence-Associated secretory phenotype from cell cycle exit via Interleukin-1 inactivation unveils its protumorigenic role. Mol. Cell. Biol. 39 (12), e00586\u2013e00518 (2019).","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"23412_CR10","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J. & Robbins, P. D. Targeting cellular senescence with senotherapeutics: Senolytics and senomorphics. FEBS J. 290 (5), 1362\u20131383 (2023).","journal-title":"FEBS J."},{"issue":"2","key":"23412_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","volume":"13","author":"I Marin","year":"2023","unstructured":"Marin, I. et al. Cellular senescence is Immunogenic and promotes antitumor immunity. Cancer Discov. 13 (2), 410\u2013431 (2023).","journal-title":"Cancer Discov"},{"issue":"3","key":"23412_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1042\/BST20190109","volume":"48","author":"K Kirschner","year":"2020","unstructured":"Kirschner, K., Rattanavirotkul, N., Quince, M. F. & Chandra, T. Functional heterogeneity in senescence. Biochem. Soc. Trans. 48 (3), 765\u2013773 (2020).","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"23412_CR13","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","volume":"128","author":"N Herranz","year":"2018","unstructured":"Herranz, N. & Gil, J. Mechanisms and functions of cellular senescence. J. Clin. Invest. 128 (4), 1238\u20131246 (2018).","journal-title":"J. Clin. Invest."},{"issue":"17","key":"23412_CR14","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.cub.2017.07.033","volume":"27","author":"A Hernandez-Segura","year":"2017","unstructured":"Hernandez-Segura, A. et al. Unmasking transcriptional heterogeneity in senescent cells. Curr. Biol. 27 (17), 2652\u20132660e4 (2017).","journal-title":"Curr. Biol."},{"issue":"9","key":"23412_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.14348\/molcells.2022.0036","volume":"45","author":"M Junaid","year":"2022","unstructured":"Junaid, M., Lee, A., Kim, J., Park, T. J. & Lim, S. B. Transcriptional heterogeneity of cellular senescence in cancer. Mol. Cells. 45 (9), 610\u2013619 (2022).","journal-title":"Mol. Cells"},{"issue":"10","key":"23412_CR16","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1002\/1878-0261.12807","volume":"15","author":"HL Ou","year":"2021","unstructured":"Ou, H. L. et al. Cellular senescence in cancer: From mechanisms to detection. Mol. Oncol. 15 (10), 2634\u20132671 (2021).","journal-title":"Mol. Oncol."},{"issue":"1","key":"23412_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13059-020-01990-9","volume":"21","author":"RA Avelar","year":"2020","unstructured":"Avelar, R. A. et al. A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol. 21 (1), 91 (2020).","journal-title":"Genome Biol."},{"issue":"5","key":"23412_CR18","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cmet.2024.03.009","volume":"36","author":"W Tao","year":"2024","unstructured":"Tao, W., Yu, Z. & Han, J. J. Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators. Cell. Metab. 36 (5), 1126\u20131143e5 (2024).","journal-title":"Cell. Metab."},{"issue":"14","key":"23412_CR19","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1093\/nar\/gkz555","volume":"47","author":"G Casella","year":"2019","unstructured":"Casella, G. et al. Transcriptome signature of cellular senescence. Nucleic Acids Res. 47 (14), 7294\u20137305 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"23412_CR20","doi-asserted-by":"publisher","first-page":"bbac118","DOI":"10.1093\/bib\/bbac118","volume":"23","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Comprehensive assessment of cellular senescence in the tumor microenvironment. Brief. Bioinform. 23 (3), bbac118 (2022).","journal-title":"Brief. Bioinform"},{"issue":"9","key":"23412_CR21","first-page":"4103","volume":"12","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Comprehensive pan-cancer analysis identifies cellular senescence as a new therapeutic target for cancer: Multi-omics analysis and single-cell sequencing validation. Am. J. Cancer Res. 12 (9), 4103\u20134119 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"23412_CR22","doi-asserted-by":"publisher","first-page":"1378356","DOI":"10.3389\/fendo.2024.1378356","volume":"15","author":"Q Xu","year":"2024","unstructured":"Xu, Q. & Feng, X. Exploring the role of cellular senescence in cancer prognosis across multiple tumor types. Front. Endocrinol. (Lausanne). 15, 1378356 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"23412_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34 (5), 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"23412_CR24","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1002\/cam4.2113","volume":"8","author":"Q Song","year":"2019","unstructured":"Song, Q. et al. Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq. Cancer Med. 8 (6), 3072\u20133085 (2019).","journal-title":"Cancer Med."},{"issue":"11","key":"23412_CR25","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","volume":"54","author":"J Zhu","year":"2022","unstructured":"Zhu, J. et al. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and Spatial transcriptomics. Exp. Mol. Med. 54 (11), 2060\u20132076 (2022).","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"23412_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-Cell analyses inform mechanisms of Myeloid-Targeted therapies in colon cancer. Cell 181 (2), 442\u2013459e29 (2020).","journal-title":"Cell"},{"issue":"11","key":"23412_CR27","doi-asserted-by":"publisher","first-page":"e0206785","DOI":"10.1371\/journal.pone.0206785","volume":"13","author":"AJ Shih","year":"2018","unstructured":"Shih, A. J. et al. Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq. PLoS One. 13 (11), e0206785 (2018).","journal-title":"PLoS One"},{"issue":"6386","key":"23412_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","volume":"360","author":"MG Filbin","year":"2018","unstructured":"Filbin, M. G. et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360 (6386), 331\u2013335 (2018).","journal-title":"Science"},{"issue":"4","key":"23412_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel, C. et al. An integrative model of cellular States, Plasticity, and genetics for glioblastoma. Cell 178 (4), 835\u2013849e21 (2019).","journal-title":"Cell"},{"issue":"1","key":"23412_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell. Biol. 23 (1), 87\u201398 (2021).","journal-title":"Nat. Cell. Biol."},{"issue":"6282","key":"23412_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352 (6282), 189\u2013196 (2016).","journal-title":"Science"},{"issue":"8","key":"23412_CR32","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 Blockade. Nat. Med. 25 (8), 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"issue":"4","key":"23412_CR33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/annonc\/mdy049","volume":"29","author":"NJ Birkbak","year":"2018","unstructured":"Birkbak, N. J. et al. Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers. Ann. Oncol. 29 (4), 903\u2013909 (2018).","journal-title":"Ann. Oncol."},{"issue":"9","key":"23412_CR34","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","volume":"52","author":"JW Cho","year":"2020","unstructured":"Cho, J. W. et al. Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer. Exp. Mol. Med. 52 (9), 1550\u20131563 (2020).","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"23412_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13148-020-00907-4","volume":"12","author":"JY Kim","year":"2020","unstructured":"Kim, J. Y., Choi, J. K. & Jung, H. Genome-wide methylation patterns predict clinical benefit of immunotherapy in lung cancer. Clin. Epigenetics. 12 (1), 119 (2020).","journal-title":"Clin. Epigenetics"},{"issue":"11","key":"23412_CR36","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","volume":"2","author":"AR Parikh","year":"2021","unstructured":"Parikh, A. R. et al. Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nat. Cancer. 2 (11), 1124\u20131135 (2021).","journal-title":"Nat. Cancer"},{"key":"23412_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2407-14-111","volume":"14","author":"G Pentheroudakis","year":"2014","unstructured":"Pentheroudakis, G. et al. A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: A translational research study of the Hellenic cooperative oncology group (HeCOG). BMC Cancer. 14, 111 (2014).","journal-title":"BMC Cancer"},{"issue":"8","key":"23412_CR38","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/bjc.2015.93","volume":"112","author":"M Verstraete","year":"2015","unstructured":"Verstraete, M. et al. Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the axebeam trial. Br. J. Cancer. 112 (8), 1314\u20131325 (2015).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"23412_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12885-017-3251-3","volume":"17","author":"T Urup","year":"2017","unstructured":"Urup, T. et al. Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients. BMC Cancer. 17 (1), 278 (2017).","journal-title":"BMC Cancer"},{"issue":"4","key":"23412_CR40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/leu.2014.298","volume":"29","author":"TP Loughran Jr","year":"2015","unstructured":"Loughran, T. P. Jr et al. Immunosuppressive therapy of LGL leukemia: Prospective multicenter phase II study by the Eastern cooperative oncology group (E5998). Leukemia 29 (4), 886\u2013894 (2015).","journal-title":"Leukemia"},{"issue":"12","key":"23412_CR41","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1158\/1078-0432.CCR-20-4443","volume":"27","author":"T van den Ende","year":"2021","unstructured":"van den Ende, T. et al. Neoadjuvant chemoradiotherapy combined with Atezolizumab for resectable esophageal adenocarcinoma: A Single-arm phase II feasibility trial (PERFECT). Clin. Cancer Res. 27 (12), 3351\u20133359 (2021).","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"23412_CR42","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1158\/1078-0432.CCR-17-0270","volume":"23","author":"ML Ascierto","year":"2017","unstructured":"Ascierto, M. L. et al. Transcriptional mechanisms of resistance to Anti-PD-1 therapy. Clin. Cancer Res. 23 (12), 3168\u20133180 (2017).","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"23412_CR43","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide, T. N. et al. Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1\/Anti-CTLA-4 combined therapy. Cancer Cell. 35 (2), 238\u2013255e6 (2019).","journal-title":"Cancer Cell."},{"issue":"1","key":"23412_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo, W. et al. Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma. Cell 165 (1), 35\u201344 (2016).","journal-title":"Cell"},{"issue":"4","key":"23412_CR45","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz, N. et al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell 171 (4), 934\u2013949e16 (2017).","journal-title":"Cell"},{"issue":"19","key":"23412_CR46","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1200\/JCO.2012.44.3762","volume":"31","author":"F Ulloa-Montoya","year":"2013","unstructured":"Ulloa-Montoya, F. et al. Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy. J. Clin. Oncol. 31 (19), 2388\u20132395 (2013).","journal-title":"J. Clin. Oncol."},{"issue":"7851","key":"23412_CR47","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-021-03326-4","volume":"591","author":"R Zappasodi","year":"2021","unstructured":"Zappasodi, R. et al. CTLA-4 Blockade drives loss of Treg stability in glycolysis-low tumours. Nature 591 (7851), 652\u2013658 (2021).","journal-title":"Nature"},{"issue":"7693","key":"23412_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 Blockade by contributing to exclusion of T cells. Nature 554 (7693), 544\u2013548 (2018).","journal-title":"Nature"},{"issue":"9","key":"23412_CR49","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41416-021-01488-6","volume":"125","author":"TL Rose","year":"2021","unstructured":"Rose, T. L. et al. Fibroblast growth factor receptor 3 alterations and response to immune checkpoint Inhibition in metastatic urothelial cancer: A real world experience. Br. J. Cancer. 125 (9), 1251\u20131260 (2021).","journal-title":"Br. J. Cancer"},{"issue":"6","key":"23412_CR50","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","volume":"26","author":"DA Braun","year":"2020","unstructured":"Braun, D. A. et al. Interplay of somatic alterations and immune infiltration modulates response to PD-1 Blockade in advanced clear cell renal cell carcinoma. Nat. Med. 26 (6), 909\u2013918 (2020).","journal-title":"Nat. Med."},{"issue":"12","key":"23412_CR51","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking. Bioinformatics 26 (12), 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"23412_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"23412_CR53","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"issue":"1","key":"23412_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer Immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint Blockade. Cell. Rep. 18 (1), 248\u2013262 (2017).","journal-title":"Cell. Rep."},{"issue":"1","key":"23412_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17 (1), 218 (2016).","journal-title":"Genome Biol."},{"issue":"5","key":"23412_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12 (5), 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"issue":"1","key":"23412_CR57","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/s41467-018-05570-1","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy, A. et al. Pan-cancer deconvolution of tumour composition using DNA methylation. Nat. Commun. 9 (1), 3220 (2018).","journal-title":"Nat. Commun."},{"issue":"4","key":"23412_CR58","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48 (4), 812\u2013830e14 (2018).","journal-title":"Immunity"},{"issue":"10","key":"23412_CR59","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer. 20 (10), 555\u2013572 (2020).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"23412_CR60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28 (1), 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"23412_CR61","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/bioinformatics\/btr254","volume":"27","author":"J Van Durme","year":"2011","unstructured":"Van Durme, J. et al. A graphical interface for the FoldX forcefield. Bioinformatics 27 (12), 1711\u20131712 (2011).","journal-title":"Bioinformatics"},{"issue":"5","key":"23412_CR62","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao, R. et al. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat. Biotechnol. 39 (5), 599\u2013608 (2021).","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"23412_CR63","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: Single-cell regulatory network inference and clustering. Nat. Methods. 14 (11), 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"issue":"1","key":"23412_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1109\/TNN.2002.804317","volume":"14","author":"FF Leung","year":"2003","unstructured":"Leung, F. F., Lam, H. K., Ling, S. H. & Tam, P. S. Tuning of the structure and parameters of a neural network using an improved genetic algorithm. IEEE Trans. Neural Netw. 14 (1), 79\u201388 (2003).","journal-title":"IEEE Trans. Neural Netw."},{"issue":"7757","key":"23412_CR65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the cancer cell line encyclopedia. Nature 569 (7757), 503\u2013508 (2019).","journal-title":"Nature"},{"issue":"3","key":"23412_CR66","doi-asserted-by":"publisher","first-page":"bbaa164","DOI":"10.1093\/bib\/bbaa164","volume":"22","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: An in Silico strategy towards precision oncology. Brief. Bioinform. 22 (3), bbaa164 (2021).","journal-title":"Brief. Bioinform."},{"issue":"7937","key":"23412_CR67","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o, J. L. et al. Effect of the intratumoral microbiota on Spatial and cellular heterogeneity in cancer. Nature 611 (7937), 810\u2013817 (2022).","journal-title":"Nature"},{"issue":"1\u20132","key":"23412_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160 (1\u20132), 48\u201361 (2015).","journal-title":"Cell"},{"issue":"7","key":"23412_CR69","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jtho.2023.03.012","volume":"18","author":"D Sun","year":"2023","unstructured":"Sun, D. et al. Classification of tumor immune microenvironment according to programmed Death-Ligand 1 expression and immune infiltration predicts response to immunotherapy plus chemotherapy in advanced patients with NSCLC. J. Thorac. Oncol. 18 (7), 869\u2013881 (2023).","journal-title":"J. Thorac. Oncol."},{"issue":"7463","key":"23412_CR70","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500 (7463), 415\u2013421 (2013).","journal-title":"Nature"},{"issue":"7","key":"23412_CR71","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrm3823","volume":"15","author":"D Mu\u00f1oz-Esp\u00edn","year":"2014","unstructured":"Mu\u00f1oz-Esp\u00edn, D. & Serrano, M. Cellular senescence: From physiology to pathology. Nat. Rev. Mol. Cell. Biol. 15 (7), 482\u2013496 (2014).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"6","key":"23412_CR72","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of cellular senescence. Trends Cell. Biol. 28 (6), 436\u2013453 (2018).","journal-title":"Trends Cell. Biol."},{"issue":"Suppl 1","key":"23412_CR73","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. Biol. Sci. Med. Sci. 69 (Suppl 1), S4\u2013S9 (2014).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"issue":"1","key":"23412_CR74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li, X. et al. Inflammation and aging: Signaling pathways and intervention therapies. Signal. Transduct. Target. Ther. 8 (1), 239 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8","key":"23412_CR75","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","volume":"22","author":"PS Hegde","year":"2016","unstructured":"Hegde, P. S., Karanikas, V. & Evers, S. The Where, the When, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint Inhibition. Clin. Cancer Res. 22 (8), 1865\u20131874 (2016).","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 7","key":"23412_CR76","doi-asserted-by":"publisher","first-page":"vii9","DOI":"10.1093\/neuonc\/nov151","volume":"17","author":"EK Nduom","year":"2015","unstructured":"Nduom, E. K., Weller, M. & Heimberger, A. B. Immunosuppressive mechanisms in glioblastoma. Neuro Oncol. 17 (Suppl 7), vii9\u2013vii14 (2015).","journal-title":"Neuro Oncol."},{"issue":"1","key":"23412_CR77","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41467-018-07825-3","volume":"9","author":"Y Ovadya","year":"2018","unstructured":"Ovadya, Y. et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat. Commun. 9 (1), 5435 (2018).","journal-title":"Nat. Commun."},{"issue":"7676","key":"23412_CR78","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"Z Dou","year":"2017","unstructured":"Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550 (7676), 402\u2013406 (2017).","journal-title":"Nature"},{"key":"23412_CR79","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1038\/ncomms3300","volume":"4","author":"JO Pyo","year":"2013","unstructured":"Pyo, J. O. et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat. Commun. 4, 2300 (2013).","journal-title":"Nat. Commun."},{"issue":"7708","key":"23412_CR80","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-018-0162-7","volume":"558","author":"\u00c1F Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez, \u00c1. F. et al. Disruption of the Beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature 558 (7708), 136\u2013140 (2018).","journal-title":"Nature"},{"key":"23412_CR81","doi-asserted-by":"publisher","first-page":"107943","DOI":"10.1016\/j.pharmthera.2021.107943","volume":"230","author":"A Basu","year":"2022","unstructured":"Basu, A. The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy. Pharmacol. Ther. 230, 107943 (2022).","journal-title":"Pharmacol. Ther."},{"issue":"25","key":"23412_CR82","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Hopkins, A. & Jaffee, E. M. Tumor mutational burden and response rate to PD-1 Inhibition. N Engl. J. Med. 377 (25), 2500\u20132501 (2017).","journal-title":"N Engl. J. Med."},{"issue":"6230","key":"23412_CR83","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 Blockade in non-small cell lung cancer. Science 348 (6230), 124\u2013128 (2015).","journal-title":"Science"},{"issue":"6411","key":"23412_CR84","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","volume":"362","author":"R Cristescu","year":"2018","unstructured":"Cristescu, R. et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362 (6411), eaar3593 (2018).","journal-title":"Science"},{"issue":"5","key":"23412_CR85","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3892\/ijo.2016.3400","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review). Int. J. Oncol. 48 (5), 1783\u20131793 (2016).","journal-title":"Int. J. Oncol."},{"issue":"4","key":"23412_CR86","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3892\/or.2021.7967","volume":"45","author":"Y Zhuang","year":"2021","unstructured":"Zhuang, Y., Li, X., Zhan, P., Pi, G. & Wen, G. MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein. Oncol. Rep. 45 (4), 16 (2021).","journal-title":"Oncol. Rep."},{"issue":"3","key":"23412_CR87","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/molecules27030811","volume":"27","author":"N Alateyah","year":"2022","unstructured":"Alateyah, N., Gupta, I., Rusyniak, R. S. & Ouhtit, A. SOD2, a potential transcriptional target underpinning CD44-Promoted breast cancer progression. Molecules 27 (3), 811 (2022).","journal-title":"Molecules"},{"issue":"27","key":"23412_CR88","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1200\/JCO.19.02404","volume":"38","author":"TA Yap","year":"2020","unstructured":"Yap, T. A. et al. Phase I trial of first-in-class ATR inhibitor M6620 (VX-970) as monotherapy or in combination with carboplatin in patients with advanced solid tumors. J. Clin. Oncol. 38 (27), 3195\u20133204 (2020).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23412-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:03:00Z","timestamp":1762977780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23412"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23412-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments were approved by the Experimental Animal Ethics Committee of Sichuan University (No. 20230307031). The utilization of tissue microarrays was approved by the Ethics Committee of Shanghai Zhuoli biotechnology Co., Ltd. (ZLL-15-01), and informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"39733"}}